Drug Delivery Device Using Polymers With Improved Tribology

THE CELANESE MT® PORTFOLIO

With more than 40 years supplying the medical device industry, Celanese now provides a broad portfolio of MT® polymers that meet the increasingly stringent demands of the medical market (Figure 9). Engineering polymers are ideal candidates for use in medical applications. They are robust, reliable, easy to process, support ergonomic design and enable easy color matching.

Figure 9: Global health megatrends challenge medical sector

Celanese MT® portfolio confers the following advantages:

1. Long-term supply assurance
2. Management of change (Up to two years notification of change commitment as per customer quality agreement)
3. Certified biocompatibility (USP 23 Class VI / ISO 10993, etc.)
4. Food contact compliance (US FDA and EU)
5. Animal- and latex-free formulations
6. US FDA Drug & Device Master file listing
7. Production according to GMP principles
8. Additional analytical & individual batch testing
9. Certificate of inspection
10.Support in regulatory approval process (requires QAC with customer)

There is no one material technology that can meet all the demands of the current and future medical technology industry. Thus, Celanese remains committed to conducting research in this field. Our broad engineering plastics technology portfolio will continue to develop and expand in accordance with new design space requirements.

Celanese®, registered C-ball design and all other trademarks identified herein with ®, TM, SM, unless otherwise noted, are trademarks of Celanese or its affiliates.

CELANESE CORPORATION
222 W. LAS COLINAS BLVD
SUITE 900N
IRVING, TX 76039.